Vinge has advised Advent International in connection with its acquisition of a minority interest in Medius

Medius is a global leader in AP automation, payments, sourcing and procurement. The company’s suite of products and services automate the process of receiving, handling, approving, and paying an invoice, and simplify the onboarding and managing of vendors.

Vinge’s team consisted primarily of Christina Kokko, Ulrich Ziche, Isabelle Wållgren, Eléonore Friberg and Elias Bohlin (M&A), Josefine Lanker (Banking & Finance), Mika Jordan (Commercial Agreements), Fredrika Hjelmberg and Karolina Fuhrman (IT/GDPR), Michael Montner (IP), and Veronika Garemark (Employment).

More information on the transaction can be found here. 


Vinge advises Blackstone in connection with its investment in Winthrop Technologies

Vinge, as local Swedish counsel, advised Blackstone Tactical Opportunities and affiliated funds (“Blackstone”) in connection with a strategic partnership with Winthrop Technologies Limited (“Winthrop Technologies”).
April 17, 2024

Vinge has advised Hansa Biopharma in connection with a directed share issue of SEK 372 million

Vinge has advised Hansa Biopharma AB (publ) in connection with a directed share issue through which the company raises proceeds of SEK 372 million before transaction costs. Hansa Biopharma is a commercial-stage biopharmaceutical company pioneering the development and commercialization of innovative, lifesaving and life altering treatments for patients with rare immunological conditions. Hansa Biopharma’s ordinary share is listed on Nasdaq Stockholm.
April 16, 2024

Vinge advises Triton in connection with the divestment of Norstat to Nalka Invest

Vinge advises Triton Smaller Mid-Cap Fund I (“Triton”) in connection with the divestment of Norstat, a leading data collector for market research, to Nalka Invest.
April 12, 2024